Alliancebernstein L.P. Next Cure, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$9.81 - $13.88 $110,352 - $156,136	-11,249 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$9.47 - $12.43 $19,934 - $26,165	-2,105 Reduced 15.76%	11,249 $123,000
Q3 2020 Nov 12, 2020	SELL	$8.15 - $21.17 $11.2 Million - $29.2 Million	-1,378,420 Reduced 99.04%	13,354 $118,000
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $2.92 Million - $5.54 Million	137,727 Added 10.98%	1,391,774 $29.8 Million
Q1 2020 May 14, 2020	BUY	$32.32 - $58.37 $6.17 Million - $11.1 Million	190,769 Added 17.94%	1,254,047 $46.5 Million
Q4 2019 Feb 18, 2020	BUY	$25.0 - $92.22 $12.4 Million - $45.6 Million	494,467 Added 86.93%	1,063,278 $59.9 Million
Q3 2019 Nov 14, 2019	SELL	$15.73 - $41.6 $2.02 Million - $5.35 Million	-128,497 Reduced 18.43%	568,811 $17.5 Million
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $9.87 Million - $14.4 Million	697,308 New	697,308 $10.4 Million

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.